Changes in the terminology and diagnostic criteria of non-alcoholic fatty liver disease: Implications and opportunities

Figure 3 Liver biopsy showing morphological changes of non-alcoholic steatohepatitis, now named metabolic dysfunction-associated steatohepatitis. There is the macro-vesicular fatty change associated with ballooned hepatocytes (green arrow), inflammation, and fibrosis. A few Mallory bodies are seen in the ballooned hepatocytes (blue arrow). This represents the progressive form of fatty disease of the liver that may progress to cirrhosis if left untreated (HE, × 200).